A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...
Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs. Objectives: Medication ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
Modern medicine is continually advancing treatment options for many chronic health conditions. For type 2 diabetes and obesity, GLP-1 receptor agonists are medications that may benefit your current ...
Medpage Today on MSN
Muscle-Sparing Weight-Loss Drugs? AID Algorithm for T2D; Steroids and Heart Attacks
Pharmaceutical companies are developing new weight-loss treatments that aim to shed the pounds while preserving muscle mass - ...
When it comes to kidney and cardiovascular outcomes, there is no significant difference between treatment with an SGLT2 inhibitor or GLP-1 receptor agonist in patients with type 2 diabetes, according ...
We interviewed a physician who provides guidance for patients with diabetes who wish to fast for religious or non-religious reasons. Fasting has been an integral part of religious practices for ...
Learning more about diabetes care — and how to go about it — can help you create a streamlined diabetes management plan and make necessary lifestyle changes. Diabetes is a chronic medical condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results